China Drug-Reaction Monitoring Clears Roche Of Questionable Drugs
This article was originally published in PharmAsia News
Chinese authorities cleared Roche of questions it may have marketed questionable drugs, including eight that include popular treatments that have been on the market in China for more than 10 years.
You may also be interested in...
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.